BigBearai Holdings Inc vs BIO-TECHNE Corp — how do they compare? BigBearai Holdings Inc trades at $3.12 (market cap $1.48B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: BIO-TECHNE Corp is far larger — about 7.5× BigBearai Holdings Inc's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while BigBearai Holdings Inc pays none. Which is the better fit depends on your goals.
| BBAI | TECH | |
|---|---|---|
Market Cap | $1.48B | $11.12B |
Sector | Technology | Health |
52-Week High | $8.91 | $71.38 |
52-Week Low | $3.05 | $43.31 |
Enterprise Value | $1.15B | $11.20B |
Dividend Yield | — | 0.45% |
Trailing returns across standard periods
Latest headlines on both assets
BigBearai Holdings Inc is a specialized provider of AI-driven decision intelligence solutions, primarily serving the U.S. defense, intelligence, and national security communities. It operationalizes complex data into actionable insights through its core modules—Observe, Orient, and Dominate—to support mission-critical operations and logistics.
Read more on BBAI →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →